199 related articles for article (PubMed ID: 16960721)
1. Effect of the CYP2D6*10 C188T polymorphism on postoperative tramadol analgesia in a Chinese population.
Wang G; Zhang H; He F; Fang X
Eur J Clin Pharmacol; 2006 Nov; 62(11):927-31. PubMed ID: 16960721
[TBL] [Abstract][Full Text] [Related]
2. Effect of the CYP2D6 gene polymorphism on postoperative analgesia of tramadol in Han nationality nephrectomy patients.
Dong H; Lu SJ; Zhang R; Liu DD; Zhang YZ; Song CY
Eur J Clin Pharmacol; 2015 Jun; 71(6):681-686. PubMed ID: 25948472
[TBL] [Abstract][Full Text] [Related]
3. Impact of CYP2D6 genotype on postoperative tramadol analgesia.
Stamer UM; Lehnen K; Höthker F; Bayerer B; Wolf S; Hoeft A; Stuber F
Pain; 2003 Sep; 105(1-2):231-8. PubMed ID: 14499440
[TBL] [Abstract][Full Text] [Related]
4. Loss-of-function polymorphisms in the organic cation transporter OCT1 are associated with reduced postoperative tramadol consumption.
Stamer UM; Musshoff F; Stüber F; Brockmöller J; Steffens M; Tzvetkov MV
Pain; 2016 Nov; 157(11):2467-2475. PubMed ID: 27541716
[TBL] [Abstract][Full Text] [Related]
5. Effect of the cytochrome P450 2D6*10 genotype on the pharmacokinetics of tramadol in post-operative patients.
Xu J; Zhang XC; Lv XQ; Xu YY; Wang GX; Jiang B; Cai L; Cai XJ
Pharmazie; 2014 Feb; 69(2):138-41. PubMed ID: 24640604
[TBL] [Abstract][Full Text] [Related]
6. Impact of CYP2D6 Polymorphisms on Postoperative Fentanyl Analgesia in Gastric Cancer Patients.
Wu SB; Cai LN; Yang XH; Fu HG; Sun K; Yuan F; Dong TL
Genet Test Mol Biomarkers; 2015 May; 19(5):248-52. PubMed ID: 25825958
[TBL] [Abstract][Full Text] [Related]
7. Tramadol efficacy in patients with postoperative pain in relation to CYP2D6 and MDR1 polymorphisms.
Slanar O; Dupal P; Matouskova O; Vondrackova H; Pafko P; Perlik F
Bratisl Lek Listy; 2012; 113(3):152-5. PubMed ID: 22428763
[TBL] [Abstract][Full Text] [Related]
8. CYP2D6*2 Polymorphism as a Predictor of Failed Outpatient Tramadol Therapy in Postherpetic Neuralgia Patients.
Nasare NV; Banerjee BD; Suryakantrao Deshmukh P; Mediratta PK; Saxena AK; Ahmed RS; Bhattacharya SN
Am J Ther; 2016; 23(3):e697-707. PubMed ID: 23567787
[TBL] [Abstract][Full Text] [Related]
9. The Associations Between CYP2D6*10 C188T Polymorphism and Pharmacokinetics and Clinical Outcomes of Tramadol: A Systematic Review and Meta-analysis.
Wen QH; Zhang Z; Cai WK; Lin XQ; He GH
Pain Med; 2020 Dec; 21(12):3679-3690. PubMed ID: 32488232
[TBL] [Abstract][Full Text] [Related]
10. Impact of CYP2D6 genetic polymorphism on tramadol pharmacokinetics and pharmacodynamics.
Gan SH; Ismail R; Wan Adnan WA; Zulmi W
Mol Diagn Ther; 2007; 11(3):171-81. PubMed ID: 17570739
[TBL] [Abstract][Full Text] [Related]
11. Concentrations of tramadol and O-desmethyltramadol enantiomers in different CYP2D6 genotypes.
Stamer UM; Musshoff F; Kobilay M; Madea B; Hoeft A; Stuber F
Clin Pharmacol Ther; 2007 Jul; 82(1):41-7. PubMed ID: 17361124
[TBL] [Abstract][Full Text] [Related]
12. Antagonistic effects of ondansetron and tramadol? A randomized placebo and active drug controlled study.
Rauers NI; Stüber F; Lee EH; Musshoff F; Fimmers R; Barann M; Stamer UM
J Pain; 2010 Dec; 11(12):1274-81. PubMed ID: 20488759
[TBL] [Abstract][Full Text] [Related]
13. The effect of
Muradian AA; Sychev DA; Blagovestnov DA; Sozaeva ZA; Akmalova KA; Zastrozhin MS; Kerimova LN; Koroshvili VT; Epifanova IA
Drug Metab Pers Ther; 2021 Jul; 37(1):27-34. PubMed ID: 35385894
[TBL] [Abstract][Full Text] [Related]
14. A logistic equation to determine the validity of tramadol from related gene polymorphisms and psychological factors.
Zhao Q; Sun J; Tao Y; Wang S; Jiang C; Zhu Y; Yu F; Zhu J
Pharmacogenomics; 2014 Mar; 15(4):487-95. PubMed ID: 24624916
[TBL] [Abstract][Full Text] [Related]
15. Correlation of tramadol pharmacokinetics and CYP2D6*10 genotype in Malaysian subjects.
Gan SH; Ismail R; Wan Adnan WA; Wan Z
J Pharm Biomed Anal; 2002 Sep; 30(2):189-195. PubMed ID: 12191703
[TBL] [Abstract][Full Text] [Related]
16. Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6) are associated with long term tramadol treatment-induced oxidative damage and hepatotoxicity.
Arafa MH; Atteia HH
Toxicol Appl Pharmacol; 2018 May; 346():37-44. PubMed ID: 29555325
[TBL] [Abstract][Full Text] [Related]
17. Post-mortem SNP analysis of CYP2D6 gene reveals correlation between genotype and opioid drug (tramadol) metabolite ratios in blood.
Levo A; Koski A; Ojanperä I; Vuori E; Sajantila A
Forensic Sci Int; 2003 Jul; 135(1):9-15. PubMed ID: 12893130
[TBL] [Abstract][Full Text] [Related]
18. CYP2D6 polymorphism in relation to tramadol metabolism: a study of faroese patients.
Halling J; Weihe P; Brosen K
Ther Drug Monit; 2008 Jun; 30(3):271-5. PubMed ID: 18520597
[TBL] [Abstract][Full Text] [Related]
19. CYP2D6 polymorphisms and codeine analgesia in postpartum pain management: a pilot study.
VanderVaart S; Berger H; Sistonen J; Madadi P; Matok I; Gijsen VM; de Wildt SN; Taddio A; Ross CJ; Carleton BC; Hayden MR; Koren G
Ther Drug Monit; 2011 Aug; 33(4):425-32. PubMed ID: 21743374
[TBL] [Abstract][Full Text] [Related]
20. Decreased Analgesic Effect of Tramadol in Japanese Patients with CYP2D6 Intermediate Metabolizers after Orthopedic Surgery.
Kamiya T; Hira D; Nakajima R; Shinoda K; Motomochi A; Morikochi A; Ikeda Y; Isono T; Akabane M; Ueshima S; Kakumoto M; Imai S; Morita SY; Terada T
Biol Pharm Bull; 2023; 46(7):907-913. PubMed ID: 37394642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]